nodes	percent_of_prediction	percent_of_DWPC	metapath
Irinotecan—Topoisomerase Inhibitors—Mitoxantrone—prostate cancer	0.17	0.354	CiPCiCtD
Irinotecan—Topoisomerase Inhibitors—Etoposide—prostate cancer	0.133	0.278	CiPCiCtD
Irinotecan—Topoisomerase Inhibitors—Epirubicin—prostate cancer	0.0919	0.191	CiPCiCtD
Irinotecan—Topoisomerase Inhibitors—Doxorubicin—prostate cancer	0.085	0.177	CiPCiCtD
Irinotecan—SLC22A3—prostate cancer	0.0614	0.366	CbGaD
Irinotecan—ACHE—prostate cancer	0.0555	0.331	CbGaD
Irinotecan—CYP3A5—prostate cancer	0.0355	0.212	CbGaD
Irinotecan—CES1—Capecitabine—prostate cancer	0.0162	0.0738	CbGbCtD
Irinotecan—CYP3A4—prostate cancer	0.0154	0.0916	CbGaD
Irinotecan—ABCC1—Abiraterone—prostate cancer	0.0121	0.055	CbGbCtD
Irinotecan—SLC22A3—Estradiol—prostate cancer	0.00769	0.035	CbGbCtD
Irinotecan—SLCO1B1—Cabazitaxel—prostate cancer	0.00754	0.0343	CbGbCtD
Irinotecan—SLCO1B1—Estrone—prostate cancer	0.00737	0.0335	CbGbCtD
Irinotecan—UGT1A1—Estradiol—prostate cancer	0.00611	0.0278	CbGbCtD
Irinotecan—ABCG2—Cabazitaxel—prostate cancer	0.00599	0.0272	CbGbCtD
Irinotecan—ABCG2—Estrone—prostate cancer	0.00585	0.0266	CbGbCtD
Irinotecan—ABCC2—Ethinyl Estradiol—prostate cancer	0.00577	0.0262	CbGbCtD
Irinotecan—ABCC1—Conjugated Estrogens—prostate cancer	0.00572	0.026	CbGbCtD
Irinotecan—ALB—Abiraterone—prostate cancer	0.00558	0.0254	CbGbCtD
Irinotecan—ABCC1—Mitoxantrone—prostate cancer	0.0052	0.0236	CbGbCtD
Irinotecan—SLCO1B1—Conjugated Estrogens—prostate cancer	0.00482	0.0219	CbGbCtD
Irinotecan—CYP3A5—Flutamide—prostate cancer	0.00448	0.0204	CbGbCtD
Irinotecan—ABCC2—Conjugated Estrogens—prostate cancer	0.00423	0.0192	CbGbCtD
Irinotecan—SLCO1B1—Estradiol—prostate cancer	0.00423	0.0192	CbGbCtD
Irinotecan—ABCC1—Epirubicin—prostate cancer	0.00421	0.0191	CbGbCtD
Irinotecan—CYP2B6—Estrone—prostate cancer	0.00412	0.0187	CbGbCtD
Irinotecan—ALB—Estrone—prostate cancer	0.00403	0.0183	CbGbCtD
Irinotecan—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.00402	0.0183	CbGbCtD
Irinotecan—UGT1A1—Etoposide—prostate cancer	0.00399	0.0181	CbGbCtD
Irinotecan—ABCG2—Conjugated Estrogens—prostate cancer	0.00383	0.0174	CbGbCtD
Irinotecan—CYP2B6—Ethinyl Estradiol—prostate cancer	0.00367	0.0167	CbGbCtD
Irinotecan—ABCG2—Mitoxantrone—prostate cancer	0.00348	0.0158	CbGbCtD
Irinotecan—ABCG2—Estradiol—prostate cancer	0.00336	0.0153	CbGbCtD
Irinotecan—CYP3A5—Cabazitaxel—prostate cancer	0.00332	0.0151	CbGbCtD
Irinotecan—ABCC1—Etoposide—prostate cancer	0.00328	0.0149	CbGbCtD
Irinotecan—ABCB1—Estramustine—prostate cancer	0.00327	0.0149	CbGbCtD
Irinotecan—CYP3A5—Estrone—prostate cancer	0.00324	0.0147	CbGbCtD
Irinotecan—ABCC1—Docetaxel—prostate cancer	0.003	0.0136	CbGbCtD
Irinotecan—CYP3A7-CYP3A51P—Estradiol—prostate cancer	0.00248	0.0113	CbGbCtD
Irinotecan—CYP3A7—Estradiol—prostate cancer	0.00248	0.0113	CbGbCtD
Irinotecan—ABCC2—Etoposide—prostate cancer	0.00243	0.011	CbGbCtD
Irinotecan—ALB—Estradiol—prostate cancer	0.00232	0.0105	CbGbCtD
Irinotecan—ABCC1—Doxorubicin—prostate cancer	0.00224	0.0102	CbGbCtD
Irinotecan—ABCC2—Docetaxel—prostate cancer	0.00222	0.0101	CbGbCtD
Irinotecan—ABCG2—Etoposide—prostate cancer	0.00219	0.00998	CbGbCtD
Irinotecan—ABCB1—Cabazitaxel—prostate cancer	0.00216	0.00981	CbGbCtD
Irinotecan—CYP3A4—Bicalutamide—prostate cancer	0.00211	0.00959	CbGbCtD
Irinotecan—ABCB1—Estrone—prostate cancer	0.00211	0.00959	CbGbCtD
Irinotecan—ABCG2—Docetaxel—prostate cancer	0.00201	0.00913	CbGbCtD
Irinotecan—ALB—Prednisone—prostate cancer	0.00199	0.00906	CbGbCtD
Irinotecan—CYP3A4—Estramustine—prostate cancer	0.00196	0.00892	CbGbCtD
Irinotecan—ABCB1—Ethinyl Estradiol—prostate cancer	0.00188	0.00855	CbGbCtD
Irinotecan—CYP3A5—Estradiol—prostate cancer	0.00186	0.00846	CbGbCtD
Irinotecan—CYP3A4—Flutamide—prostate cancer	0.00175	0.00795	CbGbCtD
Irinotecan—CYP3A4—Abiraterone—prostate cancer	0.00175	0.00795	CbGbCtD
Irinotecan—ABCC2—Doxorubicin—prostate cancer	0.00166	0.00753	CbGbCtD
Irinotecan—ABCG2—Doxorubicin—prostate cancer	0.0015	0.0068	CbGbCtD
Irinotecan—CYP3A7-CYP3A51P—Docetaxel—prostate cancer	0.00148	0.00674	CbGbCtD
Irinotecan—CYP3A7—Docetaxel—prostate cancer	0.00148	0.00674	CbGbCtD
Irinotecan—ABCB1—Conjugated Estrogens—prostate cancer	0.00138	0.00627	CbGbCtD
Irinotecan—UGT1A1—urine—prostate cancer	0.00132	0.0749	CbGeAlD
Irinotecan—CYP3A4—Cabazitaxel—prostate cancer	0.00129	0.00588	CbGbCtD
Irinotecan—CYP3A4—Estrone—prostate cancer	0.00126	0.00575	CbGbCtD
Irinotecan—ABCB1—Mitoxantrone—prostate cancer	0.00125	0.0057	CbGbCtD
Irinotecan—CYP3A5—Etoposide—prostate cancer	0.00122	0.00553	CbGbCtD
Irinotecan—ABCB1—Estradiol—prostate cancer	0.00121	0.00551	CbGbCtD
Irinotecan—TOP1MT—prostate gland—prostate cancer	0.00117	0.0661	CbGeAlD
Irinotecan—CYP3A4—Ethinyl Estradiol—prostate cancer	0.00113	0.00512	CbGbCtD
Irinotecan—CYP3A5—Docetaxel—prostate cancer	0.00111	0.00506	CbGbCtD
Irinotecan—CYP2B6—Doxorubicin—prostate cancer	0.00105	0.00479	CbGbCtD
Irinotecan—ABCB1—Prednisone—prostate cancer	0.00104	0.00474	CbGbCtD
Irinotecan—CYP3A4—Conjugated Estrogens—prostate cancer	0.000827	0.00376	CbGbCtD
Irinotecan—ABCB1—Etoposide—prostate cancer	0.000791	0.0036	CbGbCtD
Irinotecan—CYP3A4—Mitoxantrone—prostate cancer	0.000752	0.00342	CbGbCtD
Irinotecan—CYP3A4—Estradiol—prostate cancer	0.000726	0.0033	CbGbCtD
Irinotecan—ABCB1—Docetaxel—prostate cancer	0.000724	0.00329	CbGbCtD
Irinotecan—CYP3A4—Prednisone—prostate cancer	0.000624	0.00284	CbGbCtD
Irinotecan—TOP1—prostate gland—prostate cancer	0.000615	0.0349	CbGeAlD
Irinotecan—CES2—prostate gland—prostate cancer	0.000558	0.0316	CbGeAlD
Irinotecan—ABCB1—Doxorubicin—prostate cancer	0.00054	0.00245	CbGbCtD
Irinotecan—TOP1—seminal vesicle—prostate cancer	0.00052	0.0295	CbGeAlD
Irinotecan—TOP1MT—testis—prostate cancer	0.000514	0.0291	CbGeAlD
Irinotecan—UGT1A1—prostate gland—prostate cancer	0.000474	0.0269	CbGeAlD
Irinotecan—CYP3A4—Etoposide—prostate cancer	0.000474	0.00216	CbGbCtD
Irinotecan—CES2—seminal vesicle—prostate cancer	0.000472	0.0267	CbGeAlD
Irinotecan—UGT1A9—renal system—prostate cancer	0.000472	0.0267	CbGeAlD
Irinotecan—CES1—prostate gland—prostate cancer	0.000459	0.026	CbGeAlD
Irinotecan—ACHE—prostate gland—prostate cancer	0.000459	0.026	CbGeAlD
Irinotecan—CYP3A4—Docetaxel—prostate cancer	0.000434	0.00197	CbGbCtD
Irinotecan—CYP3A4—urine—prostate cancer	0.000423	0.024	CbGeAlD
Irinotecan—TOP1—urethra—prostate cancer	0.000412	0.0233	CbGeAlD
Irinotecan—CES2—renal system—prostate cancer	0.00038	0.0216	CbGeAlD
Irinotecan—CES2—urethra—prostate cancer	0.000373	0.0212	CbGeAlD
Irinotecan—TOP1MT—lymph node—prostate cancer	0.000372	0.0211	CbGeAlD
Irinotecan—Topotecan—CYP3A4—prostate cancer	0.000338	1	CrCbGaD
Irinotecan—CYP3A4—Doxorubicin—prostate cancer	0.000323	0.00147	CbGbCtD
Irinotecan—UGT1A1—renal system—prostate cancer	0.000323	0.0183	CbGeAlD
Irinotecan—SLC22A3—prostate gland—prostate cancer	0.000319	0.0181	CbGeAlD
Irinotecan—TOP1—bone marrow—prostate cancer	0.000317	0.018	CbGeAlD
Irinotecan—ABCC2—prostate gland—prostate cancer	0.000299	0.017	CbGeAlD
Irinotecan—CES2—bone marrow—prostate cancer	0.000287	0.0163	CbGeAlD
Irinotecan—TOP1—testis—prostate cancer	0.000271	0.0154	CbGeAlD
Irinotecan—SLC22A3—seminal vesicle—prostate cancer	0.00027	0.0153	CbGeAlD
Irinotecan—SLCO1B1—renal system—prostate cancer	0.000269	0.0153	CbGeAlD
Irinotecan—ABCC1—prostate gland—prostate cancer	0.000264	0.0149	CbGeAlD
Irinotecan—CES2—testis—prostate cancer	0.000246	0.0139	CbGeAlD
Irinotecan—BCHE—prostate gland—prostate cancer	0.000226	0.0128	CbGeAlD
Irinotecan—ABCC1—seminal vesicle—prostate cancer	0.000223	0.0126	CbGeAlD
Irinotecan—ABCG2—prostate gland—prostate cancer	0.000218	0.0124	CbGeAlD
Irinotecan—SLC22A3—renal system—prostate cancer	0.000217	0.0123	CbGeAlD
Irinotecan—SLC22A3—urethra—prostate cancer	0.000213	0.0121	CbGeAlD
Irinotecan—ABCC2—renal system—prostate cancer	0.000204	0.0116	CbGeAlD
Irinotecan—CYP3A5—prostate gland—prostate cancer	0.000203	0.0115	CbGeAlD
Irinotecan—ACHE—testis—prostate cancer	0.000202	0.0115	CbGeAlD
Irinotecan—CES1—testis—prostate cancer	0.000202	0.0115	CbGeAlD
Irinotecan—TOP1—lymph node—prostate cancer	0.000196	0.0111	CbGeAlD
Irinotecan—BCHE—seminal vesicle—prostate cancer	0.000191	0.0108	CbGeAlD
Irinotecan—ABCG2—seminal vesicle—prostate cancer	0.000185	0.0105	CbGeAlD
Irinotecan—CES2—lymph node—prostate cancer	0.000178	0.0101	CbGeAlD
Irinotecan—ABCC1—urethra—prostate cancer	0.000176	0.01	CbGeAlD
Irinotecan—ACHE—lymph node—prostate cancer	0.000147	0.00832	CbGeAlD
Irinotecan—CES1—lymph node—prostate cancer	0.000147	0.00832	CbGeAlD
Irinotecan—ABCG2—urethra—prostate cancer	0.000146	0.00828	CbGeAlD
Irinotecan—ALB—testis—prostate cancer	0.000141	0.00798	CbGeAlD
Irinotecan—SLC22A3—testis—prostate cancer	0.00014	0.00796	CbGeAlD
Irinotecan—CYP3A5—renal system—prostate cancer	0.000138	0.00783	CbGeAlD
Irinotecan—CYP2B6—renal system—prostate cancer	0.000137	0.00778	CbGeAlD
Irinotecan—ABCC2—testis—prostate cancer	0.000132	0.00747	CbGeAlD
Irinotecan—BCHE—bone marrow—prostate cancer	0.000116	0.0066	CbGeAlD
Irinotecan—ABCC1—testis—prostate cancer	0.000116	0.00658	CbGeAlD
Irinotecan—ABCG2—bone marrow—prostate cancer	0.000112	0.00637	CbGeAlD
Irinotecan—ABCB1—prostate gland—prostate cancer	0.000108	0.0061	CbGeAlD
Irinotecan—CYP3A4—renal system—prostate cancer	0.000104	0.00587	CbGeAlD
Irinotecan—ALB—lymph node—prostate cancer	0.000102	0.00578	CbGeAlD
Irinotecan—SLC22A3—lymph node—prostate cancer	0.000102	0.00577	CbGeAlD
Irinotecan—BCHE—testis—prostate cancer	9.94e-05	0.00564	CbGeAlD
Irinotecan—ABCG2—testis—prostate cancer	9.61e-05	0.00545	CbGeAlD
Irinotecan—ABCC2—lymph node—prostate cancer	9.55e-05	0.00542	CbGeAlD
Irinotecan—ABCB1—seminal vesicle—prostate cancer	9.1e-05	0.00516	CbGeAlD
Irinotecan—CYP2B6—testis—prostate cancer	8.87e-05	0.00503	CbGeAlD
Irinotecan—ABCC1—lymph node—prostate cancer	8.41e-05	0.00477	CbGeAlD
Irinotecan—ABCB1—epithelium—prostate cancer	7.9e-05	0.00448	CbGeAlD
Irinotecan—ABCB1—renal system—prostate cancer	7.33e-05	0.00416	CbGeAlD
Irinotecan—BCHE—lymph node—prostate cancer	7.21e-05	0.00409	CbGeAlD
Irinotecan—ABCB1—urethra—prostate cancer	7.2e-05	0.00408	CbGeAlD
Irinotecan—ABCG2—lymph node—prostate cancer	6.97e-05	0.00395	CbGeAlD
Irinotecan—ABCB1—bone marrow—prostate cancer	5.54e-05	0.00314	CbGeAlD
Irinotecan—ABCB1—testis—prostate cancer	4.74e-05	0.00269	CbGeAlD
Irinotecan—ABCB1—lymph node—prostate cancer	3.44e-05	0.00195	CbGeAlD
Irinotecan—Upper respiratory tract infection—Doxorubicin—prostate cancer	1.43e-05	0.000215	CcSEcCtD
Irinotecan—Sweating—Epirubicin—prostate cancer	1.43e-05	0.000213	CcSEcCtD
Irinotecan—Confusional state—Docetaxel—prostate cancer	1.42e-05	0.000212	CcSEcCtD
Irinotecan—Anaphylactic shock—Docetaxel—prostate cancer	1.41e-05	0.000211	CcSEcCtD
Irinotecan—Oedema—Docetaxel—prostate cancer	1.41e-05	0.000211	CcSEcCtD
Irinotecan—Discomfort—Capecitabine—prostate cancer	1.4e-05	0.00021	CcSEcCtD
Irinotecan—Infection—Docetaxel—prostate cancer	1.4e-05	0.000209	CcSEcCtD
Irinotecan—Weight decreased—Doxorubicin—prostate cancer	1.4e-05	0.000209	CcSEcCtD
Irinotecan—Feeling abnormal—Etoposide—prostate cancer	1.39e-05	0.000209	CcSEcCtD
Irinotecan—Diarrhoea—Mitoxantrone—prostate cancer	1.39e-05	0.000208	CcSEcCtD
Irinotecan—Vomiting—Estradiol—prostate cancer	1.39e-05	0.000208	CcSEcCtD
Irinotecan—Pneumonia—Doxorubicin—prostate cancer	1.38e-05	0.000207	CcSEcCtD
Irinotecan—Gastrointestinal pain—Etoposide—prostate cancer	1.38e-05	0.000207	CcSEcCtD
Irinotecan—Shock—Docetaxel—prostate cancer	1.38e-05	0.000207	CcSEcCtD
Irinotecan—Nervous system disorder—Docetaxel—prostate cancer	1.38e-05	0.000206	CcSEcCtD
Irinotecan—Ill-defined disorder—Prednisone—prostate cancer	1.38e-05	0.000206	CcSEcCtD
Irinotecan—Thrombocytopenia—Docetaxel—prostate cancer	1.38e-05	0.000206	CcSEcCtD
Irinotecan—Rash—Estradiol—prostate cancer	1.38e-05	0.000206	CcSEcCtD
Irinotecan—Dermatitis—Estradiol—prostate cancer	1.38e-05	0.000206	CcSEcCtD
Irinotecan—Anaemia—Prednisone—prostate cancer	1.37e-05	0.000206	CcSEcCtD
Irinotecan—Confusional state—Capecitabine—prostate cancer	1.37e-05	0.000206	CcSEcCtD
Irinotecan—Headache—Estradiol—prostate cancer	1.37e-05	0.000205	CcSEcCtD
Irinotecan—Oedema—Capecitabine—prostate cancer	1.36e-05	0.000204	CcSEcCtD
Irinotecan—Bradycardia—Epirubicin—prostate cancer	1.36e-05	0.000203	CcSEcCtD
Irinotecan—Renal failure—Doxorubicin—prostate cancer	1.35e-05	0.000203	CcSEcCtD
Irinotecan—Infection—Capecitabine—prostate cancer	1.35e-05	0.000202	CcSEcCtD
Irinotecan—Haemoglobin—Epirubicin—prostate cancer	1.34e-05	0.000201	CcSEcCtD
Irinotecan—Stomatitis—Doxorubicin—prostate cancer	1.34e-05	0.000201	CcSEcCtD
Irinotecan—Jaundice—Doxorubicin—prostate cancer	1.34e-05	0.000201	CcSEcCtD
Irinotecan—Anorexia—Docetaxel—prostate cancer	1.34e-05	0.000201	CcSEcCtD
Irinotecan—Malaise—Prednisone—prostate cancer	1.34e-05	0.000201	CcSEcCtD
Irinotecan—Shock—Capecitabine—prostate cancer	1.34e-05	0.000201	CcSEcCtD
Irinotecan—Rhinitis—Epirubicin—prostate cancer	1.34e-05	0.0002	CcSEcCtD
Irinotecan—Abdominal pain—Etoposide—prostate cancer	1.34e-05	0.0002	CcSEcCtD
Irinotecan—Body temperature increased—Etoposide—prostate cancer	1.34e-05	0.0002	CcSEcCtD
Irinotecan—Nervous system disorder—Capecitabine—prostate cancer	1.34e-05	0.0002	CcSEcCtD
Irinotecan—Vertigo—Prednisone—prostate cancer	1.33e-05	0.0002	CcSEcCtD
Irinotecan—Haemorrhage—Epirubicin—prostate cancer	1.33e-05	0.0002	CcSEcCtD
Irinotecan—Thrombocytopenia—Capecitabine—prostate cancer	1.33e-05	0.0002	CcSEcCtD
Irinotecan—Syncope—Prednisone—prostate cancer	1.33e-05	0.000199	CcSEcCtD
Irinotecan—Sweating—Doxorubicin—prostate cancer	1.32e-05	0.000197	CcSEcCtD
Irinotecan—Hyperhidrosis—Capecitabine—prostate cancer	1.32e-05	0.000197	CcSEcCtD
Irinotecan—Hypotension—Docetaxel—prostate cancer	1.31e-05	0.000197	CcSEcCtD
Irinotecan—Connective tissue disorder—Epirubicin—prostate cancer	1.31e-05	0.000196	CcSEcCtD
Irinotecan—Loss of consciousness—Prednisone—prostate cancer	1.31e-05	0.000196	CcSEcCtD
Irinotecan—Anorexia—Capecitabine—prostate cancer	1.3e-05	0.000194	CcSEcCtD
Irinotecan—Nausea—Estradiol—prostate cancer	1.3e-05	0.000194	CcSEcCtD
Irinotecan—Vomiting—Mitoxantrone—prostate cancer	1.29e-05	0.000194	CcSEcCtD
Irinotecan—Visual impairment—Epirubicin—prostate cancer	1.29e-05	0.000193	CcSEcCtD
Irinotecan—Hypertension—Prednisone—prostate cancer	1.28e-05	0.000192	CcSEcCtD
Irinotecan—Rash—Mitoxantrone—prostate cancer	1.28e-05	0.000192	CcSEcCtD
Irinotecan—Dermatitis—Mitoxantrone—prostate cancer	1.28e-05	0.000192	CcSEcCtD
Irinotecan—Headache—Mitoxantrone—prostate cancer	1.27e-05	0.000191	CcSEcCtD
Irinotecan—Hypotension—Capecitabine—prostate cancer	1.27e-05	0.00019	CcSEcCtD
Irinotecan—Insomnia—Docetaxel—prostate cancer	1.27e-05	0.00019	CcSEcCtD
Irinotecan—Paraesthesia—Docetaxel—prostate cancer	1.26e-05	0.000189	CcSEcCtD
Irinotecan—Bradycardia—Doxorubicin—prostate cancer	1.26e-05	0.000188	CcSEcCtD
Irinotecan—Dyspnoea—Docetaxel—prostate cancer	1.25e-05	0.000188	CcSEcCtD
Irinotecan—Somnolence—Docetaxel—prostate cancer	1.25e-05	0.000187	CcSEcCtD
Irinotecan—Discomfort—Prednisone—prostate cancer	1.25e-05	0.000187	CcSEcCtD
Irinotecan—Hypersensitivity—Etoposide—prostate cancer	1.25e-05	0.000187	CcSEcCtD
Irinotecan—Haemoglobin—Doxorubicin—prostate cancer	1.24e-05	0.000186	CcSEcCtD
Irinotecan—Flushing—Epirubicin—prostate cancer	1.24e-05	0.000185	CcSEcCtD
Irinotecan—Cardiac disorder—Epirubicin—prostate cancer	1.24e-05	0.000185	CcSEcCtD
Irinotecan—Rhinitis—Doxorubicin—prostate cancer	1.24e-05	0.000185	CcSEcCtD
Irinotecan—Dyspepsia—Docetaxel—prostate cancer	1.24e-05	0.000185	CcSEcCtD
Irinotecan—Haemorrhage—Doxorubicin—prostate cancer	1.24e-05	0.000185	CcSEcCtD
Irinotecan—Insomnia—Capecitabine—prostate cancer	1.23e-05	0.000184	CcSEcCtD
Irinotecan—Paraesthesia—Capecitabine—prostate cancer	1.22e-05	0.000183	CcSEcCtD
Irinotecan—Decreased appetite—Docetaxel—prostate cancer	1.22e-05	0.000183	CcSEcCtD
Irinotecan—Gastrointestinal disorder—Docetaxel—prostate cancer	1.21e-05	0.000182	CcSEcCtD
Irinotecan—Asthenia—Etoposide—prostate cancer	1.21e-05	0.000182	CcSEcCtD
Irinotecan—Connective tissue disorder—Doxorubicin—prostate cancer	1.21e-05	0.000182	CcSEcCtD
Irinotecan—Dyspnoea—Capecitabine—prostate cancer	1.21e-05	0.000182	CcSEcCtD
Irinotecan—Anaphylactic shock—Prednisone—prostate cancer	1.21e-05	0.000182	CcSEcCtD
Irinotecan—Oedema—Prednisone—prostate cancer	1.21e-05	0.000182	CcSEcCtD
Irinotecan—Fatigue—Docetaxel—prostate cancer	1.21e-05	0.000182	CcSEcCtD
Irinotecan—Angiopathy—Epirubicin—prostate cancer	1.21e-05	0.000181	CcSEcCtD
Irinotecan—Nausea—Mitoxantrone—prostate cancer	1.21e-05	0.000181	CcSEcCtD
Irinotecan—Immune system disorder—Epirubicin—prostate cancer	1.21e-05	0.000181	CcSEcCtD
Irinotecan—Infection—Prednisone—prostate cancer	1.2e-05	0.00018	CcSEcCtD
Irinotecan—Mediastinal disorder—Epirubicin—prostate cancer	1.2e-05	0.00018	CcSEcCtD
Irinotecan—Pain—Docetaxel—prostate cancer	1.2e-05	0.00018	CcSEcCtD
Irinotecan—Constipation—Docetaxel—prostate cancer	1.2e-05	0.00018	CcSEcCtD
Irinotecan—Dyspepsia—Capecitabine—prostate cancer	1.2e-05	0.000179	CcSEcCtD
Irinotecan—Chills—Epirubicin—prostate cancer	1.2e-05	0.000179	CcSEcCtD
Irinotecan—Shock—Prednisone—prostate cancer	1.19e-05	0.000179	CcSEcCtD
Irinotecan—Arrhythmia—Epirubicin—prostate cancer	1.19e-05	0.000179	CcSEcCtD
Irinotecan—Visual impairment—Doxorubicin—prostate cancer	1.19e-05	0.000178	CcSEcCtD
Irinotecan—Nervous system disorder—Prednisone—prostate cancer	1.19e-05	0.000178	CcSEcCtD
Irinotecan—Decreased appetite—Capecitabine—prostate cancer	1.18e-05	0.000177	CcSEcCtD
Irinotecan—Alopecia—Epirubicin—prostate cancer	1.18e-05	0.000177	CcSEcCtD
Irinotecan—Gastrointestinal disorder—Capecitabine—prostate cancer	1.18e-05	0.000176	CcSEcCtD
Irinotecan—Fatigue—Capecitabine—prostate cancer	1.17e-05	0.000176	CcSEcCtD
Irinotecan—Hyperhidrosis—Prednisone—prostate cancer	1.17e-05	0.000176	CcSEcCtD
Irinotecan—Constipation—Capecitabine—prostate cancer	1.16e-05	0.000174	CcSEcCtD
Irinotecan—Pain—Capecitabine—prostate cancer	1.16e-05	0.000174	CcSEcCtD
Irinotecan—Feeling abnormal—Docetaxel—prostate cancer	1.16e-05	0.000173	CcSEcCtD
Irinotecan—Diarrhoea—Etoposide—prostate cancer	1.16e-05	0.000173	CcSEcCtD
Irinotecan—Anorexia—Prednisone—prostate cancer	1.16e-05	0.000173	CcSEcCtD
Irinotecan—Gastrointestinal pain—Docetaxel—prostate cancer	1.15e-05	0.000172	CcSEcCtD
Irinotecan—Flushing—Doxorubicin—prostate cancer	1.15e-05	0.000172	CcSEcCtD
Irinotecan—Cardiac disorder—Doxorubicin—prostate cancer	1.15e-05	0.000172	CcSEcCtD
Irinotecan—Flatulence—Epirubicin—prostate cancer	1.15e-05	0.000171	CcSEcCtD
Irinotecan—Back pain—Epirubicin—prostate cancer	1.12e-05	0.000168	CcSEcCtD
Irinotecan—Feeling abnormal—Capecitabine—prostate cancer	1.12e-05	0.000168	CcSEcCtD
Irinotecan—Angiopathy—Doxorubicin—prostate cancer	1.12e-05	0.000168	CcSEcCtD
Irinotecan—Dizziness—Etoposide—prostate cancer	1.12e-05	0.000168	CcSEcCtD
Irinotecan—Muscle spasms—Epirubicin—prostate cancer	1.12e-05	0.000167	CcSEcCtD
Irinotecan—Immune system disorder—Doxorubicin—prostate cancer	1.12e-05	0.000167	CcSEcCtD
Irinotecan—Gastrointestinal pain—Capecitabine—prostate cancer	1.11e-05	0.000167	CcSEcCtD
Irinotecan—Mediastinal disorder—Doxorubicin—prostate cancer	1.11e-05	0.000167	CcSEcCtD
Irinotecan—Abdominal pain—Docetaxel—prostate cancer	1.11e-05	0.000166	CcSEcCtD
Irinotecan—Body temperature increased—Docetaxel—prostate cancer	1.11e-05	0.000166	CcSEcCtD
Irinotecan—Chills—Doxorubicin—prostate cancer	1.11e-05	0.000166	CcSEcCtD
Irinotecan—Arrhythmia—Doxorubicin—prostate cancer	1.1e-05	0.000165	CcSEcCtD
Irinotecan—Insomnia—Prednisone—prostate cancer	1.1e-05	0.000164	CcSEcCtD
Irinotecan—Alopecia—Doxorubicin—prostate cancer	1.09e-05	0.000163	CcSEcCtD
Irinotecan—Paraesthesia—Prednisone—prostate cancer	1.09e-05	0.000163	CcSEcCtD
Irinotecan—Ill-defined disorder—Epirubicin—prostate cancer	1.08e-05	0.000161	CcSEcCtD
Irinotecan—Abdominal pain—Capecitabine—prostate cancer	1.08e-05	0.000161	CcSEcCtD
Irinotecan—Body temperature increased—Capecitabine—prostate cancer	1.08e-05	0.000161	CcSEcCtD
Irinotecan—Vomiting—Etoposide—prostate cancer	1.08e-05	0.000161	CcSEcCtD
Irinotecan—Anaemia—Epirubicin—prostate cancer	1.07e-05	0.000161	CcSEcCtD
Irinotecan—Dyspepsia—Prednisone—prostate cancer	1.07e-05	0.00016	CcSEcCtD
Irinotecan—Rash—Etoposide—prostate cancer	1.07e-05	0.00016	CcSEcCtD
Irinotecan—Dermatitis—Etoposide—prostate cancer	1.07e-05	0.00016	CcSEcCtD
Irinotecan—Headache—Etoposide—prostate cancer	1.06e-05	0.000159	CcSEcCtD
Irinotecan—Flatulence—Doxorubicin—prostate cancer	1.06e-05	0.000159	CcSEcCtD
Irinotecan—Decreased appetite—Prednisone—prostate cancer	1.05e-05	0.000158	CcSEcCtD
Irinotecan—Malaise—Epirubicin—prostate cancer	1.05e-05	0.000157	CcSEcCtD
Irinotecan—Fatigue—Prednisone—prostate cancer	1.05e-05	0.000157	CcSEcCtD
Irinotecan—Vertigo—Epirubicin—prostate cancer	1.04e-05	0.000156	CcSEcCtD
Irinotecan—Syncope—Epirubicin—prostate cancer	1.04e-05	0.000156	CcSEcCtD
Irinotecan—Leukopenia—Epirubicin—prostate cancer	1.04e-05	0.000156	CcSEcCtD
Irinotecan—Back pain—Doxorubicin—prostate cancer	1.04e-05	0.000156	CcSEcCtD
Irinotecan—Constipation—Prednisone—prostate cancer	1.04e-05	0.000155	CcSEcCtD
Irinotecan—Hypersensitivity—Docetaxel—prostate cancer	1.04e-05	0.000155	CcSEcCtD
Irinotecan—Muscle spasms—Doxorubicin—prostate cancer	1.03e-05	0.000155	CcSEcCtD
Irinotecan—Loss of consciousness—Epirubicin—prostate cancer	1.02e-05	0.000153	CcSEcCtD
Irinotecan—Cough—Epirubicin—prostate cancer	1.01e-05	0.000152	CcSEcCtD
Irinotecan—Asthenia—Docetaxel—prostate cancer	1.01e-05	0.000151	CcSEcCtD
Irinotecan—Nausea—Etoposide—prostate cancer	1e-05	0.00015	CcSEcCtD
Irinotecan—Hypertension—Epirubicin—prostate cancer	1e-05	0.00015	CcSEcCtD
Irinotecan—Hypersensitivity—Capecitabine—prostate cancer	1e-05	0.00015	CcSEcCtD
Irinotecan—Feeling abnormal—Prednisone—prostate cancer	9.99e-06	0.00015	CcSEcCtD
Irinotecan—Ill-defined disorder—Doxorubicin—prostate cancer	9.98e-06	0.000149	CcSEcCtD
Irinotecan—Anaemia—Doxorubicin—prostate cancer	9.94e-06	0.000149	CcSEcCtD
Irinotecan—Gastrointestinal pain—Prednisone—prostate cancer	9.92e-06	0.000148	CcSEcCtD
Irinotecan—Discomfort—Epirubicin—prostate cancer	9.77e-06	0.000146	CcSEcCtD
Irinotecan—Asthenia—Capecitabine—prostate cancer	9.77e-06	0.000146	CcSEcCtD
Irinotecan—Malaise—Doxorubicin—prostate cancer	9.7e-06	0.000145	CcSEcCtD
Irinotecan—Vertigo—Doxorubicin—prostate cancer	9.66e-06	0.000145	CcSEcCtD
Irinotecan—Syncope—Doxorubicin—prostate cancer	9.64e-06	0.000144	CcSEcCtD
Irinotecan—Leukopenia—Doxorubicin—prostate cancer	9.62e-06	0.000144	CcSEcCtD
Irinotecan—Diarrhoea—Docetaxel—prostate cancer	9.62e-06	0.000144	CcSEcCtD
Irinotecan—Abdominal pain—Prednisone—prostate cancer	9.59e-06	0.000144	CcSEcCtD
Irinotecan—Body temperature increased—Prednisone—prostate cancer	9.59e-06	0.000144	CcSEcCtD
Irinotecan—Confusional state—Epirubicin—prostate cancer	9.56e-06	0.000143	CcSEcCtD
Irinotecan—Oedema—Epirubicin—prostate cancer	9.48e-06	0.000142	CcSEcCtD
Irinotecan—Anaphylactic shock—Epirubicin—prostate cancer	9.48e-06	0.000142	CcSEcCtD
Irinotecan—Loss of consciousness—Doxorubicin—prostate cancer	9.45e-06	0.000141	CcSEcCtD
Irinotecan—Infection—Epirubicin—prostate cancer	9.42e-06	0.000141	CcSEcCtD
Irinotecan—Cough—Doxorubicin—prostate cancer	9.38e-06	0.00014	CcSEcCtD
Irinotecan—Shock—Epirubicin—prostate cancer	9.33e-06	0.00014	CcSEcCtD
Irinotecan—Diarrhoea—Capecitabine—prostate cancer	9.31e-06	0.000139	CcSEcCtD
Irinotecan—Nervous system disorder—Epirubicin—prostate cancer	9.3e-06	0.000139	CcSEcCtD
Irinotecan—Dizziness—Docetaxel—prostate cancer	9.3e-06	0.000139	CcSEcCtD
Irinotecan—Thrombocytopenia—Epirubicin—prostate cancer	9.29e-06	0.000139	CcSEcCtD
Irinotecan—Hypertension—Doxorubicin—prostate cancer	9.28e-06	0.000139	CcSEcCtD
Irinotecan—Hyperhidrosis—Epirubicin—prostate cancer	9.17e-06	0.000137	CcSEcCtD
Irinotecan—Discomfort—Doxorubicin—prostate cancer	9.04e-06	0.000135	CcSEcCtD
Irinotecan—Anorexia—Epirubicin—prostate cancer	9.04e-06	0.000135	CcSEcCtD
Irinotecan—Dizziness—Capecitabine—prostate cancer	9e-06	0.000135	CcSEcCtD
Irinotecan—Vomiting—Docetaxel—prostate cancer	8.94e-06	0.000134	CcSEcCtD
Irinotecan—Hypersensitivity—Prednisone—prostate cancer	8.93e-06	0.000134	CcSEcCtD
Irinotecan—Rash—Docetaxel—prostate cancer	8.87e-06	0.000133	CcSEcCtD
Irinotecan—Hypotension—Epirubicin—prostate cancer	8.86e-06	0.000133	CcSEcCtD
Irinotecan—Dermatitis—Docetaxel—prostate cancer	8.86e-06	0.000133	CcSEcCtD
Irinotecan—Confusional state—Doxorubicin—prostate cancer	8.85e-06	0.000132	CcSEcCtD
Irinotecan—Headache—Docetaxel—prostate cancer	8.81e-06	0.000132	CcSEcCtD
Irinotecan—Anaphylactic shock—Doxorubicin—prostate cancer	8.78e-06	0.000131	CcSEcCtD
Irinotecan—Oedema—Doxorubicin—prostate cancer	8.78e-06	0.000131	CcSEcCtD
Irinotecan—Infection—Doxorubicin—prostate cancer	8.72e-06	0.000131	CcSEcCtD
Irinotecan—Asthenia—Prednisone—prostate cancer	8.7e-06	0.00013	CcSEcCtD
Irinotecan—Vomiting—Capecitabine—prostate cancer	8.66e-06	0.00013	CcSEcCtD
Irinotecan—Shock—Doxorubicin—prostate cancer	8.63e-06	0.000129	CcSEcCtD
Irinotecan—Nervous system disorder—Doxorubicin—prostate cancer	8.61e-06	0.000129	CcSEcCtD
Irinotecan—Thrombocytopenia—Doxorubicin—prostate cancer	8.59e-06	0.000129	CcSEcCtD
Irinotecan—Rash—Capecitabine—prostate cancer	8.58e-06	0.000129	CcSEcCtD
Irinotecan—Insomnia—Epirubicin—prostate cancer	8.58e-06	0.000128	CcSEcCtD
Irinotecan—Dermatitis—Capecitabine—prostate cancer	8.58e-06	0.000128	CcSEcCtD
Irinotecan—Headache—Capecitabine—prostate cancer	8.53e-06	0.000128	CcSEcCtD
Irinotecan—Paraesthesia—Epirubicin—prostate cancer	8.52e-06	0.000128	CcSEcCtD
Irinotecan—Hyperhidrosis—Doxorubicin—prostate cancer	8.48e-06	0.000127	CcSEcCtD
Irinotecan—Dyspnoea—Epirubicin—prostate cancer	8.46e-06	0.000127	CcSEcCtD
Irinotecan—Somnolence—Epirubicin—prostate cancer	8.43e-06	0.000126	CcSEcCtD
Irinotecan—Anorexia—Doxorubicin—prostate cancer	8.36e-06	0.000125	CcSEcCtD
Irinotecan—Nausea—Docetaxel—prostate cancer	8.35e-06	0.000125	CcSEcCtD
Irinotecan—Dyspepsia—Epirubicin—prostate cancer	8.35e-06	0.000125	CcSEcCtD
Irinotecan—Diarrhoea—Prednisone—prostate cancer	8.3e-06	0.000124	CcSEcCtD
Irinotecan—Decreased appetite—Epirubicin—prostate cancer	8.24e-06	0.000123	CcSEcCtD
Irinotecan—Hypotension—Doxorubicin—prostate cancer	8.2e-06	0.000123	CcSEcCtD
Irinotecan—Gastrointestinal disorder—Epirubicin—prostate cancer	8.19e-06	0.000123	CcSEcCtD
Irinotecan—Fatigue—Epirubicin—prostate cancer	8.18e-06	0.000122	CcSEcCtD
Irinotecan—Pain—Epirubicin—prostate cancer	8.11e-06	0.000121	CcSEcCtD
Irinotecan—Constipation—Epirubicin—prostate cancer	8.11e-06	0.000121	CcSEcCtD
Irinotecan—Nausea—Capecitabine—prostate cancer	8.09e-06	0.000121	CcSEcCtD
Irinotecan—Dizziness—Prednisone—prostate cancer	8.02e-06	0.00012	CcSEcCtD
Irinotecan—Insomnia—Doxorubicin—prostate cancer	7.94e-06	0.000119	CcSEcCtD
Irinotecan—Paraesthesia—Doxorubicin—prostate cancer	7.88e-06	0.000118	CcSEcCtD
Irinotecan—Dyspnoea—Doxorubicin—prostate cancer	7.82e-06	0.000117	CcSEcCtD
Irinotecan—Feeling abnormal—Epirubicin—prostate cancer	7.82e-06	0.000117	CcSEcCtD
Irinotecan—Somnolence—Doxorubicin—prostate cancer	7.8e-06	0.000117	CcSEcCtD
Irinotecan—Gastrointestinal pain—Epirubicin—prostate cancer	7.76e-06	0.000116	CcSEcCtD
Irinotecan—Dyspepsia—Doxorubicin—prostate cancer	7.72e-06	0.000116	CcSEcCtD
Irinotecan—Vomiting—Prednisone—prostate cancer	7.71e-06	0.000115	CcSEcCtD
Irinotecan—Rash—Prednisone—prostate cancer	7.65e-06	0.000114	CcSEcCtD
Irinotecan—Dermatitis—Prednisone—prostate cancer	7.64e-06	0.000114	CcSEcCtD
Irinotecan—Decreased appetite—Doxorubicin—prostate cancer	7.63e-06	0.000114	CcSEcCtD
Irinotecan—Headache—Prednisone—prostate cancer	7.6e-06	0.000114	CcSEcCtD
Irinotecan—Gastrointestinal disorder—Doxorubicin—prostate cancer	7.58e-06	0.000113	CcSEcCtD
Irinotecan—Fatigue—Doxorubicin—prostate cancer	7.57e-06	0.000113	CcSEcCtD
Irinotecan—Constipation—Doxorubicin—prostate cancer	7.5e-06	0.000112	CcSEcCtD
Irinotecan—Pain—Doxorubicin—prostate cancer	7.5e-06	0.000112	CcSEcCtD
Irinotecan—Abdominal pain—Epirubicin—prostate cancer	7.5e-06	0.000112	CcSEcCtD
Irinotecan—Body temperature increased—Epirubicin—prostate cancer	7.5e-06	0.000112	CcSEcCtD
Irinotecan—Feeling abnormal—Doxorubicin—prostate cancer	7.23e-06	0.000108	CcSEcCtD
Irinotecan—Nausea—Prednisone—prostate cancer	7.2e-06	0.000108	CcSEcCtD
Irinotecan—Gastrointestinal pain—Doxorubicin—prostate cancer	7.18e-06	0.000107	CcSEcCtD
Irinotecan—Hypersensitivity—Epirubicin—prostate cancer	6.99e-06	0.000105	CcSEcCtD
Irinotecan—Abdominal pain—Doxorubicin—prostate cancer	6.94e-06	0.000104	CcSEcCtD
Irinotecan—Body temperature increased—Doxorubicin—prostate cancer	6.94e-06	0.000104	CcSEcCtD
Irinotecan—Asthenia—Epirubicin—prostate cancer	6.8e-06	0.000102	CcSEcCtD
Irinotecan—Diarrhoea—Epirubicin—prostate cancer	6.49e-06	9.72e-05	CcSEcCtD
Irinotecan—Hypersensitivity—Doxorubicin—prostate cancer	6.47e-06	9.68e-05	CcSEcCtD
Irinotecan—Asthenia—Doxorubicin—prostate cancer	6.3e-06	9.43e-05	CcSEcCtD
Irinotecan—Dizziness—Epirubicin—prostate cancer	6.27e-06	9.39e-05	CcSEcCtD
Irinotecan—Vomiting—Epirubicin—prostate cancer	6.03e-06	9.03e-05	CcSEcCtD
Irinotecan—Diarrhoea—Doxorubicin—prostate cancer	6e-06	8.99e-05	CcSEcCtD
Irinotecan—Rash—Epirubicin—prostate cancer	5.98e-06	8.95e-05	CcSEcCtD
Irinotecan—Dermatitis—Epirubicin—prostate cancer	5.97e-06	8.94e-05	CcSEcCtD
Irinotecan—Headache—Epirubicin—prostate cancer	5.94e-06	8.9e-05	CcSEcCtD
Irinotecan—Dizziness—Doxorubicin—prostate cancer	5.8e-06	8.69e-05	CcSEcCtD
Irinotecan—Nausea—Epirubicin—prostate cancer	5.63e-06	8.43e-05	CcSEcCtD
Irinotecan—Vomiting—Doxorubicin—prostate cancer	5.58e-06	8.35e-05	CcSEcCtD
Irinotecan—Rash—Doxorubicin—prostate cancer	5.53e-06	8.28e-05	CcSEcCtD
Irinotecan—Dermatitis—Doxorubicin—prostate cancer	5.53e-06	8.28e-05	CcSEcCtD
Irinotecan—Headache—Doxorubicin—prostate cancer	5.5e-06	8.23e-05	CcSEcCtD
Irinotecan—Nausea—Doxorubicin—prostate cancer	5.21e-06	7.8e-05	CcSEcCtD
Irinotecan—CYP3A4—Metabolism—SLC22A3—prostate cancer	7.47e-07	1.59e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—GGT1—prostate cancer	7.38e-07	1.57e-05	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—CREBBP—prostate cancer	7.34e-07	1.56e-05	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—PIK3CG—prostate cancer	7.33e-07	1.56e-05	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—PIK3CD—prostate cancer	7.32e-07	1.56e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—TYMS—prostate cancer	7.32e-07	1.56e-05	CbGpPWpGaD
Irinotecan—SLC22A3—Metabolism—EP300—prostate cancer	7.3e-07	1.56e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—NCOA1—prostate cancer	7.26e-07	1.55e-05	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—PIK3CG—prostate cancer	7.26e-07	1.55e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—GSTM1—prostate cancer	7.23e-07	1.54e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—SLC5A5—prostate cancer	7.21e-07	1.54e-05	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—NOS3—prostate cancer	7.17e-07	1.53e-05	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—NOS3—prostate cancer	7.17e-07	1.53e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—CYP19A1—prostate cancer	7.16e-07	1.53e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—GSTA4—prostate cancer	7.16e-07	1.53e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—TBXAS1—prostate cancer	7.16e-07	1.53e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—TYMS—prostate cancer	7.15e-07	1.52e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—CDKN1B—prostate cancer	7.15e-07	1.52e-05	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—PIK3CD—prostate cancer	7.14e-07	1.52e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—LPL—prostate cancer	7.1e-07	1.51e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—GSTM1—prostate cancer	7.07e-07	1.51e-05	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—EP300—prostate cancer	7.04e-07	1.5e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—CYP2E1—prostate cancer	7.04e-07	1.5e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—GSTA2—prostate cancer	6.97e-07	1.49e-05	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—PIK3CB—prostate cancer	6.97e-07	1.49e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—NQO1—prostate cancer	6.96e-07	1.48e-05	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—PIK3CD—prostate cancer	6.96e-07	1.48e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—LPL—prostate cancer	6.94e-07	1.48e-05	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—INS—prostate cancer	6.93e-07	1.48e-05	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—NOS3—prostate cancer	6.91e-07	1.47e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—RXRA—prostate cancer	6.91e-07	1.47e-05	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—PTGS2—prostate cancer	6.91e-07	1.47e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—SULT1A1—prostate cancer	6.89e-07	1.47e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—ABCG5—prostate cancer	6.89e-07	1.47e-05	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—INS—prostate cancer	6.87e-07	1.46e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—TH—prostate cancer	6.86e-07	1.46e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—CYP1A1—prostate cancer	6.86e-07	1.46e-05	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—SRC—prostate cancer	6.85e-07	1.46e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—ERCC2—prostate cancer	6.8e-07	1.45e-05	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—CREBBP—prostate cancer	6.79e-07	1.45e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—CYP3A4—prostate cancer	6.79e-07	1.45e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—CTNNB1—prostate cancer	6.75e-07	1.44e-05	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—NOS3—prostate cancer	6.74e-07	1.44e-05	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—CREBBP—prostate cancer	6.73e-07	1.43e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—GSTA1—prostate cancer	6.73e-07	1.43e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	6.72e-07	1.43e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—CYP1A1—prostate cancer	6.7e-07	1.43e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—CYP1B1—prostate cancer	6.67e-07	1.42e-05	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—VEGFA—prostate cancer	6.67e-07	1.42e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—COMT—prostate cancer	6.66e-07	1.42e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—NAT2—prostate cancer	6.65e-07	1.42e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—HSD3B2—prostate cancer	6.65e-07	1.42e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—GSTO1—prostate cancer	6.65e-07	1.42e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—ERCC2—prostate cancer	6.65e-07	1.42e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—GSTP1—prostate cancer	6.62e-07	1.41e-05	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—PIK3CB—prostate cancer	6.62e-07	1.41e-05	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—PIK3CB—prostate cancer	6.62e-07	1.41e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—CDKN1A—prostate cancer	6.6e-07	1.41e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—PTEN—prostate cancer	6.58e-07	1.4e-05	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—NOS3—prostate cancer	6.57e-07	1.4e-05	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—PTGS2—prostate cancer	6.56e-07	1.4e-05	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—PTGS2—prostate cancer	6.56e-07	1.4e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—ITPR1—prostate cancer	6.52e-07	1.39e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—GGT1—prostate cancer	6.46e-07	1.38e-05	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—PIK3CD—prostate cancer	6.44e-07	1.37e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism of lipids and lipoproteins—EP300—prostate cancer	6.41e-07	1.37e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—MTHFR—prostate cancer	6.39e-07	1.36e-05	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—PIK3CD—prostate cancer	6.38e-07	1.36e-05	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—PIK3CB—prostate cancer	6.38e-07	1.36e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—PLCB2—prostate cancer	6.38e-07	1.36e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—LRP2—prostate cancer	6.38e-07	1.36e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—CYP2C18—prostate cancer	6.38e-07	1.36e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—NCOA1—prostate cancer	6.37e-07	1.36e-05	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—PTGS2—prostate cancer	6.32e-07	1.35e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—EP300—prostate cancer	6.28e-07	1.34e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—CYP19A1—prostate cancer	6.27e-07	1.34e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—PPARA—prostate cancer	6.27e-07	1.34e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—P4HB—prostate cancer	6.26e-07	1.33e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—MTHFR—prostate cancer	6.25e-07	1.33e-05	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—PIK3CB—prostate cancer	6.22e-07	1.33e-05	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—PTGS2—prostate cancer	6.16e-07	1.31e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—TYMS—prostate cancer	6.16e-07	1.31e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—PPARA—prostate cancer	6.13e-07	1.31e-05	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—TGFB1—prostate cancer	6.12e-07	1.3e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—SRC—prostate cancer	6.1e-07	1.3e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—GSTM1—prostate cancer	6.09e-07	1.3e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—SLC22A1—prostate cancer	6.09e-07	1.3e-05	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—NOS3—prostate cancer	6.08e-07	1.3e-05	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—PIK3CB—prostate cancer	6.06e-07	1.29e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—RXRA—prostate cancer	6.05e-07	1.29e-05	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—NOS3—prostate cancer	6.03e-07	1.28e-05	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—PTEN—prostate cancer	6.02e-07	1.28e-05	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—PTGS2—prostate cancer	6.01e-07	1.28e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—LPL—prostate cancer	5.98e-07	1.27e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—SULT2A1—prostate cancer	5.93e-07	1.26e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—CAV1—prostate cancer	5.9e-07	1.26e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—STAT3—prostate cancer	5.89e-07	1.25e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—MED12—prostate cancer	5.83e-07	1.24e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—COMT—prostate cancer	5.83e-07	1.24e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—GSTP1—prostate cancer	5.8e-07	1.24e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—GNG5—prostate cancer	5.79e-07	1.23e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—CYP1A1—prostate cancer	5.77e-07	1.23e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—CAV1—prostate cancer	5.76e-07	1.23e-05	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—EP300—prostate cancer	5.75e-07	1.22e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—ERCC2—prostate cancer	5.72e-07	1.22e-05	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—PTEN—prostate cancer	5.72e-07	1.22e-05	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—PTEN—prostate cancer	5.72e-07	1.22e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—ITPR1—prostate cancer	5.71e-07	1.22e-05	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—KRAS—prostate cancer	5.67e-07	1.21e-05	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—PIK3CB—prostate cancer	5.61e-07	1.2e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—NCOA3—prostate cancer	5.58e-07	1.19e-05	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—PIK3CB—prostate cancer	5.56e-07	1.19e-05	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—PTGS2—prostate cancer	5.56e-07	1.19e-05	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—PTGS2—prostate cancer	5.51e-07	1.17e-05	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—PTEN—prostate cancer	5.51e-07	1.17e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—MYC—prostate cancer	5.47e-07	1.17e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—TGFB1—prostate cancer	5.46e-07	1.16e-05	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—EP300—prostate cancer	5.45e-07	1.16e-05	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—EP300—prostate cancer	5.45e-07	1.16e-05	CbGpPWpGaD
Irinotecan—SLC22A3—Metabolism—PIK3CA—prostate cancer	5.4e-07	1.15e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—TYMS—prostate cancer	5.4e-07	1.15e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—MTHFR—prostate cancer	5.38e-07	1.15e-05	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—PTEN—prostate cancer	5.37e-07	1.15e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—PIK3CG—prostate cancer	5.37e-07	1.14e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—EGFR—prostate cancer	5.35e-07	1.14e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—GSTM1—prostate cancer	5.33e-07	1.14e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—HPGDS—prostate cancer	5.32e-07	1.13e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—CYP2C19—prostate cancer	5.29e-07	1.13e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—PPARA—prostate cancer	5.28e-07	1.12e-05	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—EP300—prostate cancer	5.26e-07	1.12e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—PIK3CG—prostate cancer	5.25e-07	1.12e-05	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—PTEN—prostate cancer	5.24e-07	1.12e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—LPL—prostate cancer	5.24e-07	1.12e-05	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—PIK3CA—prostate cancer	5.21e-07	1.11e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—GSTT1—prostate cancer	5.16e-07	1.1e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—ACHE—prostate cancer	5.16e-07	1.1e-05	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—EP300—prostate cancer	5.13e-07	1.09e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—CYP2A6—prostate cancer	5.1e-07	1.09e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—INS—prostate cancer	5.08e-07	1.08e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—CYP1A1—prostate cancer	5.06e-07	1.08e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—KRAS—prostate cancer	5.05e-07	1.08e-05	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—TP53—prostate cancer	5.04e-07	1.07e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—ERCC2—prostate cancer	5.02e-07	1.07e-05	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—EP300—prostate cancer	5e-07	1.06e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—CREBBP—prostate cancer	4.98e-07	1.06e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—INS—prostate cancer	4.97e-07	1.06e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—CAV1—prostate cancer	4.96e-07	1.06e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—AKR1C3—prostate cancer	4.96e-07	1.06e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—PRKACB—prostate cancer	4.93e-07	1.05e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—CYP17A1—prostate cancer	4.88e-07	1.04e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—CREBBP—prostate cancer	4.87e-07	1.04e-05	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—PTEN—prostate cancer	4.85e-07	1.03e-05	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—PTEN—prostate cancer	4.81e-07	1.02e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	4.74e-07	1.01e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—PIK3CD—prostate cancer	4.72e-07	1.01e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—MTHFR—prostate cancer	4.71e-07	1e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—NCOA2—prostate cancer	4.65e-07	9.92e-06	CbGpPWpGaD
Irinotecan—ABCC1—Disease—PIK3CA—prostate cancer	4.64e-07	9.89e-06	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—EP300—prostate cancer	4.63e-07	9.86e-06	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—PPARA—prostate cancer	4.62e-07	9.86e-06	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—PIK3CD—prostate cancer	4.61e-07	9.83e-06	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—EP300—prostate cancer	4.59e-07	9.77e-06	CbGpPWpGaD
Irinotecan—ALB—Metabolism—PIK3CG—prostate cancer	4.52e-07	9.63e-06	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—NOS3—prostate cancer	4.46e-07	9.5e-06	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—SLC5A5—prostate cancer	4.44e-07	9.46e-06	CbGpPWpGaD
Irinotecan—SLC22A3—Metabolism—AKT1—prostate cancer	4.41e-07	9.4e-06	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—NOS3—prostate cancer	4.36e-07	9.28e-06	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—CAV1—prostate cancer	4.35e-07	9.27e-06	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—CYP2E1—prostate cancer	4.34e-07	9.24e-06	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—NQO1—prostate cancer	4.29e-07	9.14e-06	CbGpPWpGaD
Irinotecan—ALB—Metabolism—INS—prostate cancer	4.28e-07	9.12e-06	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—AKT1—prostate cancer	4.25e-07	9.07e-06	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—PIK3CA—prostate cancer	4.25e-07	9.06e-06	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—TH—prostate cancer	4.23e-07	9e-06	CbGpPWpGaD
Irinotecan—ALB—Metabolism—CREBBP—prostate cancer	4.19e-07	8.93e-06	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—PIK3CB—prostate cancer	4.11e-07	8.77e-06	CbGpPWpGaD
Irinotecan—ABCC1—Disease—IL6—prostate cancer	4.11e-07	8.76e-06	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—CYP1B1—prostate cancer	4.11e-07	8.76e-06	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—PTGS2—prostate cancer	4.08e-07	8.69e-06	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—PIK3CA—prostate cancer	4.03e-07	8.59e-06	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—PIK3CA—prostate cancer	4.03e-07	8.59e-06	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—PIK3CB—prostate cancer	4.02e-07	8.57e-06	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—PTGS2—prostate cancer	3.99e-07	8.49e-06	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—GGT1—prostate cancer	3.98e-07	8.48e-06	CbGpPWpGaD
Irinotecan—ALB—Metabolism—PIK3CD—prostate cancer	3.97e-07	8.47e-06	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—PIK3CG—prostate cancer	3.96e-07	8.44e-06	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—NCOA1—prostate cancer	3.92e-07	8.36e-06	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—PIK3CA—prostate cancer	3.89e-07	8.29e-06	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—CYP19A1—prostate cancer	3.86e-07	8.24e-06	CbGpPWpGaD
Irinotecan—ABCC1—Disease—AKT1—prostate cancer	3.79e-07	8.08e-06	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—PIK3CA—prostate cancer	3.79e-07	8.08e-06	CbGpPWpGaD
Irinotecan—ALB—Metabolism—NOS3—prostate cancer	3.75e-07	8e-06	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—INS—prostate cancer	3.75e-07	7.99e-06	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—RXRA—prostate cancer	3.73e-07	7.95e-06	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—PIK3CA—prostate cancer	3.7e-07	7.88e-06	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—CREBBP—prostate cancer	3.67e-07	7.83e-06	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—COMT—prostate cancer	3.59e-07	7.66e-06	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—GSTP1—prostate cancer	3.58e-07	7.62e-06	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—PTEN—prostate cancer	3.56e-07	7.58e-06	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—ITPR1—prostate cancer	3.52e-07	7.5e-06	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—PIK3CD—prostate cancer	3.48e-07	7.42e-06	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—PTEN—prostate cancer	3.48e-07	7.41e-06	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—AKT1—prostate cancer	3.47e-07	7.4e-06	CbGpPWpGaD
Irinotecan—ALB—Metabolism—PIK3CB—prostate cancer	3.46e-07	7.38e-06	CbGpPWpGaD
Irinotecan—ALB—Metabolism—PTGS2—prostate cancer	3.43e-07	7.31e-06	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—PIK3CA—prostate cancer	3.42e-07	7.29e-06	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—PIK3CA—prostate cancer	3.39e-07	7.23e-06	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—EP300—prostate cancer	3.39e-07	7.23e-06	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—TYMS—prostate cancer	3.32e-07	7.08e-06	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—EP300—prostate cancer	3.31e-07	7.06e-06	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—AKT1—prostate cancer	3.29e-07	7.02e-06	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—AKT1—prostate cancer	3.29e-07	7.02e-06	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—NOS3—prostate cancer	3.29e-07	7.01e-06	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—GSTM1—prostate cancer	3.29e-07	7e-06	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—LPL—prostate cancer	3.23e-07	6.87e-06	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—AKT1—prostate cancer	3.18e-07	6.77e-06	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—CYP1A1—prostate cancer	3.12e-07	6.64e-06	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—AKT1—prostate cancer	3.1e-07	6.6e-06	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—ERCC2—prostate cancer	3.09e-07	6.58e-06	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—PIK3CB—prostate cancer	3.03e-07	6.47e-06	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—AKT1—prostate cancer	3.02e-07	6.43e-06	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—PTGS2—prostate cancer	3.01e-07	6.41e-06	CbGpPWpGaD
Irinotecan—ALB—Metabolism—PTEN—prostate cancer	2.99e-07	6.38e-06	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—MTHFR—prostate cancer	2.9e-07	6.19e-06	CbGpPWpGaD
Irinotecan—ALB—Metabolism—EP300—prostate cancer	2.85e-07	6.08e-06	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—PPARA—prostate cancer	2.85e-07	6.07e-06	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—AKT1—prostate cancer	2.8e-07	5.96e-06	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—AKT1—prostate cancer	2.77e-07	5.9e-06	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—CAV1—prostate cancer	2.68e-07	5.71e-06	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—PTEN—prostate cancer	2.62e-07	5.59e-06	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—PIK3CA—prostate cancer	2.51e-07	5.35e-06	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—EP300—prostate cancer	2.5e-07	5.33e-06	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—PIK3CA—prostate cancer	2.45e-07	5.22e-06	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—PIK3CG—prostate cancer	2.44e-07	5.2e-06	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—INS—prostate cancer	2.31e-07	4.92e-06	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—CREBBP—prostate cancer	2.26e-07	4.82e-06	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—PIK3CD—prostate cancer	2.15e-07	4.57e-06	CbGpPWpGaD
Irinotecan—ALB—Metabolism—PIK3CA—prostate cancer	2.11e-07	4.5e-06	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—AKT1—prostate cancer	2.05e-07	4.37e-06	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—NOS3—prostate cancer	2.03e-07	4.32e-06	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—AKT1—prostate cancer	2e-07	4.27e-06	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—PIK3CB—prostate cancer	1.87e-07	3.98e-06	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—PTGS2—prostate cancer	1.85e-07	3.95e-06	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—PIK3CA—prostate cancer	1.85e-07	3.94e-06	CbGpPWpGaD
Irinotecan—ALB—Metabolism—AKT1—prostate cancer	1.72e-07	3.68e-06	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—PTEN—prostate cancer	1.62e-07	3.44e-06	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—EP300—prostate cancer	1.54e-07	3.28e-06	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—AKT1—prostate cancer	1.51e-07	3.22e-06	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—PIK3CA—prostate cancer	1.14e-07	2.43e-06	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—AKT1—prostate cancer	9.31e-08	1.98e-06	CbGpPWpGaD
